ACR Appropriateness Criteria® Pretreatment Evaluation and Follow-Up of Endometrial Cancer.

[1]  Yuanyuan Shi,et al.  Diagnostic Value of Assessment of Cervical Involvement in Early-Stage Endometrial Adenocarcinoma: Comparison of Magnetic Resonance Imaging (MRI) Versus Hysteroscopy , 2018, Medical science monitor : international medical journal of experimental and clinical research.

[2]  Y. Hatano,et al.  Inchworm sign of endometrial cancer on diffusion-weighted MRI: radiology-pathology correlation. , 2018, Clinical radiology.

[3]  F. Amant,et al.  Cancer of the corpus uteri , 2018, International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics.

[4]  K. Brouwer,et al.  Stigma and unmet sexual and reproductive health needs among international migrant sex workers at the Mexico–Guatemala border , 2018, International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics.

[5]  M. Ohmichi,et al.  The diagnostic accuracy of fluorodeoxyglucose-positron emission tomography/computed tomography and sentinel node biopsy in the prediction of pelvic lymph node metastasis in patients with endometrial cancer , 2018, Medicine.

[6]  P. Bhosale,et al.  Can MRI help assess aggressiveness of endometrial cancer? , 2018, Clinical radiology.

[7]  E. Sala,et al.  Endometrial Cancer MRI staging: Updated Guidelines of the European Society of Urogenital Radiology , 2018, European Radiology.

[8]  N. Yu,et al.  The utility of measuring the apparent diffusion coefficient for peritumoral zone in assessing infiltration depth of endometrial cancer , 2018, Cancer Imaging.

[9]  N. Khandelwal,et al.  Read-out segmented echo planar diffusion imaging of the female pelvis-utility in endometrial carcinoma-a preliminary experience. , 2018, The British journal of radiology.

[10]  S. Çerçi,et al.  Incidence of suspicious axillary lymph node involvement in fluorine-18 fluoro-D-glucose positron emission tomography/computed tomography in gynecologic cancers , 2018, Turkish journal of obstetrics and gynecology.

[11]  Wenxia Yu,et al.  Diagnostic value of 18F-FDG PET/MRI in recurrent pelvis malignancies of female patients: a systematic review and meta-analysis , 2018, Nuclear medicine communications.

[12]  A. Ferri,et al.  Pre-operative MRI staging of endometrial cancer in a multicentre cancer network: can we match single centre study results? , 2018, European Radiology.

[13]  Hongyan Ni,et al.  Myometrial invasion and overall staging of endometrial carcinoma: assessment using fusion of T2-weighted magnetic resonance imaging and diffusion-weighted magnetic resonance imaging , 2017, OncoTargets and therapy.

[14]  M. Gee,et al.  Identification of Distant Metastatic Disease in Uterine Cervical and Endometrial Cancers with FDG PET/CT: Analysis from the ACRIN 6671/GOG 0233 Multicenter Trial. , 2017, Radiology.

[15]  J. Boggess,et al.  Sentinel lymph node mapping and staging in endometrial cancer: A Society of Gynecologic Oncology literature review with consensus recommendations. , 2017, Gynecologic oncology.

[16]  N. Khanna,et al.  An update on post-treatment surveillance and diagnosis of recurrence in women with gynecologic malignancies: Society of Gynecologic Oncology (SGO) recommendations. , 2017, Gynecologic oncology.

[17]  Caroline Reinhold,et al.  Endometrial Carcinoma: MR Imaging-based Texture Model for Preoperative Risk Stratification-A Preliminary Analysis. , 2017, Radiology.

[18]  Linghong Guo,et al.  Diagnostic role of 18F-FDG PET/MRI in patients with gynecological malignancies of the pelvis: A systematic review and meta-analysis , 2017, PloS one.

[19]  S. Ng,et al.  Endometrial cancer with cervical stromal invasion: diagnostic accuracy of diffusion-weighted and dynamic contrast enhanced MR imaging at 3T , 2017, European Radiology.

[20]  A. Ivanova,et al.  A comparison of sentinel lymph node biopsy to lymphadenectomy for endometrial cancer staging (FIRES trial): a multicentre, prospective, cohort study. , 2017, The Lancet. Oncology.

[21]  Lino Morris Sawicki,et al.  Whole-body staging of female patients with recurrent pelvic malignancies: Ultra-fast 18F-FDG PET/MRI compared to 18F-FDG PET/CT and CT , 2017, PloS one.

[22]  H. Salvesen,et al.  High Diagnostic Value of 18F-FDG PET/CT in Endometrial Cancer: Systematic Review and Meta-Analysis of the Literature , 2016, The Journal of Nuclear Medicine.

[23]  Derya Yakar,et al.  Diagnostic Performance of Computed Tomography for Preoperative Staging of Patients with Non-endometrioid Carcinomas of the Uterine Corpus , 2016, Annals of Surgical Oncology.

[24]  J. Ledermann,et al.  ESMO-ESGO-ESTRO Consensus Conference on Endometrial Cancer , 2015, International Journal of Gynecologic Cancer.

[25]  Kathy L. MacLaughlin,et al.  Surveillance and Care of the Gynecologic Cancer Survivor , 2015, Journal of women's health.

[26]  J. Alcázar,et al.  Transvaginal/transrectal ultrasound for assessing myometrial invasion in endometrial cancer: a comparison of six different approaches , 2015, Journal of gynecologic oncology.

[27]  E. Lengyel,et al.  Patterns and utility of routine surveillance in high grade endometrial cancer. , 2015, Gynecologic oncology.

[28]  P. Veit-Haibach,et al.  PET/MRI and PET/CT in advanced gynaecological tumours: initial experience and comparison , 2015, European Radiology.

[29]  E. Sala,et al.  Endometrial Cancer: Combined MR Volumetry and Diffusion-weighted Imaging for Assessment of Myometrial and Lymphovascular Invasion and Tumor Grade. , 2015, Radiology.

[30]  S. Faria,et al.  Imaging in endometrial carcinoma , 2015, Indian Journal of Radiology and Imaging.

[31]  S. Das,et al.  Usefulness of DWI in preoperative assessment of deep myometrial invasion in patients with endometrial carcinoma: a systematic review and meta-analysis , 2014, Cancer Imaging.

[32]  R. Manfredi,et al.  Which imaging technique should we use in the follow up of gynaecological cancer? , 2014, Best practice & research. Clinical obstetrics & gynaecology.

[33]  B. Weigelt,et al.  Classification of endometrial carcinoma: more than two types. , 2014, The Lancet. Oncology.

[34]  C. Coutant,et al.  A clue towards improving the European Society of Medical Oncology risk group classification in apparent early stage endometrial cancer? Impact of lymphovascular space invasion , 2014, British Journal of Cancer.

[35]  N. Abu-Rustum.  Sentinel lymph node mapping for endometrial cancer: a modern approach to surgical staging. , 2014, Journal of the National Comprehensive Cancer Network : JNCCN.

[36]  D. Doherty,et al.  Transtubal spread of endometrial carcinoma: correlation of intra-luminal tumour cells with tumour grade, peritoneal fluid cytology, and extra-uterine metastasis , 2013, Pathology.

[37]  H. Hricak,et al.  Role of preoperative MR imaging in the evaluation of patients with persistent or recurrent gynaecological malignancies before pelvic exenteration , 2013, European Radiology.

[38]  R. Farina,et al.  Endometrial carcinoma: MR staging and causes of error , 2013, La radiologia medica.

[39]  J. Jagannathan,et al.  Typical and atypical metastatic sites of recurrent endometrial carcinoma , 2013, Cancer imaging : the official publication of the International Cancer Imaging Society.

[40]  D. Mitchell,et al.  The added role of MR imaging in treatment stratification of patients with gynecologic malignancies: what the radiologist needs to know. , 2013, Radiology.

[41]  G. Treglia,et al.  Accuracy of 18-F-FDG PET imaging in the follow up of endometrial cancer patients: systematic review and meta-analysis of the literature. , 2013, Gynecologic oncology.

[42]  J. Trovik,et al.  Magnetic resonance imaging performs better than endocervical curettage for preoperative prediction of cervical stromal invasion in endometrial carcinomas. , 2012, Gynecologic oncology.

[43]  M. Senda,et al.  Prognostic significance of SUVmax (maximum standardized uptake value) measured by [18F]FDG PET/CT in endometrial cancer , 2012, European Journal of Nuclear Medicine and Molecular Imaging.

[44]  E. Sala,et al.  Evaluation of depth of myometrial invasion and overall staging in endometrial cancer: comparison of diffusion-weighted and dynamic contrast-enhanced MR imaging. , 2012, Radiology.

[45]  Qingli Zhu,et al.  Imaging of Endometrial Carcinoma Using Contrast‐Enhanced Sonography , 2011, Journal of ultrasound in medicine : official journal of the American Institute of Ultrasound in Medicine.

[46]  D. Fischerová.  Ultrasound scanning of the pelvis and abdomen for staging of gynecological tumors: a review , 2011, Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology.

[47]  O. Guralp,et al.  Iatrogenic transtubal spill of endometrial cancer: risk or myth , 2011, Archives of Gynecology and Obstetrics.

[48]  D. Levine,et al.  Sentinel lymph node mapping for endometrial cancer improves the detection of metastatic disease to regional lymph nodes. , 2011, Gynecologic oncology.

[49]  M. Senda,et al.  Preoperative nodal staging of uterine cancer: is contrast-enhanced PET/CT more accurate than non-enhanced PET/CT or enhanced CT alone? , 2011, Annals of nuclear medicine.

[50]  B. Goff,et al.  Posttreatment surveillance and diagnosis of recurrence in women with gynecologic malignancies: Society of Gynecologic Oncologists recommendations. , 2011, American journal of obstetrics and gynecology.

[51]  Young Tae Kim,et al.  Comparison of FDG PET/CT and MRI in lymph node staging of endometrial cancer , 2011, Annals of Nuclear Medicine.

[52]  M. Kaneuchi,et al.  Survival effect of para-aortic lymphadenectomy in endometrial cancer (SEPAL study): a retrospective cohort analysis , 2010, The Lancet.

[53]  D. Levine,et al.  A nomogram for predicting overall survival of women with endometrial cancer following primary therapy: toward improving individualized cancer care. , 2010, Gynecologic oncology.

[54]  S. Galimberti,et al.  Myometrial invasion in endometrial cancer: diagnostic performance of diffusion-weighted MR imaging at 1.5-T , 2010, European Radiology.

[55]  K. Matsuzaki,et al.  Diffusion-weighted magnetic resonance imaging of endometrial cancer: differentiation from benign endometrial lesions and preoperative assessment of myometrial invasion , 2009, Acta radiologica.

[56]  T. Murakami,et al.  MR imaging of endometrial carcinoma for preoperative staging at 3.0 T: Comparison with imaging at 1.5 T , 2009, Journal of magnetic resonance imaging : JMRI.

[57]  E. Miyagi,et al.  Analysis of stage IVB endometrial carcinoma patients with distant metastasis: a review of prognoses in 55 patients , 2009, International Journal of Clinical Oncology.

[58]  R. Reznek,et al.  Pearls and pitfalls of MR lymphography in gynecologic malignancy. , 2009, Radiographics : a review publication of the Radiological Society of North America, Inc.

[59]  S. Pecorelli.  Revised FIGO staging for carcinoma of the vulva, cervix, and endometrium , 2009 .

[60]  M. Parmar,et al.  Efficacy of systematic pelvic lymphadenectomy in endometrial cancer (MRC ASTEC trial): a randomised study , 2009, The Lancet.

[61]  E. Sala,et al.  Added Value of Dynamic Contrast-Enhanced Magnetic Resonance Imaging in Predicting Advanced Stage Disease in Patients With Endometrial Carcinoma , 2009, International Journal of Gynecologic Cancer.

[62]  F. Mazzariol,et al.  Efficacy of contrast-enhanced CT in assessing the endometrium. , 2008, AJR. American journal of roentgenology.

[63]  T. Yen,et al.  Detection of lymph node metastasis in cervical and uterine cancers by diffusion‐weighted magnetic resonance imaging at 3T , 2008, Journal of magnetic resonance imaging : JMRI.

[64]  G. Ferrandina,et al.  Preoperative local staging of endometrial cancer: transvaginal sonography vs. magnetic resonance imaging , 2008, Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology.

[65]  G. Ligabue,et al.  3-T MRI in the preoperative evaluation of depth of myometrial infiltration in endometrial cancer. , 2008, AJR. American journal of roentgenology.

[66]  J. Berek,et al.  Prognostic factors and risk of extrauterine metastases in 3867 women with grade 1 endometrioid corpus cancer. , 2008, American journal of obstetrics and gynecology.

[67]  C. Tsampoulas,et al.  Local staging of endometrial carcinoma: role of multidetector CT , 2008, European Radiology.

[68]  E. Sartori,et al.  Pattern of failure and value of follow-up procedures in endometrial and cervical cancer patients. , 2007, Gynecologic oncology.

[69]  E. Sala,et al.  [MRI of malignant neoplasms of the uterine corpus and cervix]. , 2007, Radiologia.

[70]  S. Dobbs,et al.  The diagnostic accuracy of magnetic resonance imaging in detecting cervical involvement in endometrial cancer. , 2006, Gynecologic oncology.

[71]  R. Reznek,et al.  Evaluation of endometrial carcinoma on magnetic resonance imaging , 2006, International Journal of Gynecologic Cancer.

[72]  T. Oliver,et al.  Follow-up after primary therapy for endometrial cancer: a systematic review. , 2006, Gynecologic oncology.

[73]  G. Ambrosini,et al.  Risks and usefulness of sonohysterography in patients with endometrial carcinoma. , 2006, American journal of obstetrics and gynecology.

[74]  G. Scambia,et al.  Local-regional staging of endometrial carcinoma: role of MR imaging in surgical planning. , 2004, Radiology.

[75]  K. Togashi,et al.  Clinical value of FDG-PET in the follow up of post-operative patients with endometrial cancer , 2003, Annals of nuclear medicine.

[76]  S. Costantini,et al.  [The role of transvaginal ultrasound and sonohysterography in the diagnosis and staging of endometrial adenocarcinoma]. , 2001, La Radiologia medica.

[77]  R. Buller,et al.  Computed Tomography in Endometrial Carcinoma , 2000, Obstetrics and gynecology.

[78]  A. Gadducci,et al.  An intensive follow-up does not change survival of patients with clinical stage I endometrial cancer. , 2000, Anticancer research.

[79]  P. Koper,et al.  Surgery and postoperative radiotherapy versus surgery alone for patients with stage-1 endometrial carcinoma: multicentre randomised trial , 2000, The Lancet.

[80]  M. Segal,et al.  Radiologic staging in patients with endometrial cancer: a meta-analysis. , 1999, Radiology.

[81]  A. Berchuck,et al.  Postsurgical surveillance of patients with FIGO stage I/II endometrial adenocarcinoma. , 1995, Gynecologic oncology.

[82]  Y. Song,et al.  Detection of Deep Myometrial Invasion in Endometrial Carcinoma: Comparison of Trans vaginal Ultrasound, CT, and MRI , 1995, Journal of computer assisted tomography.

[83]  J. Shepherd.  Revised FIGO staging for gynaecological cancer , 1989, British journal of obstetrics and gynaecology.

[84]  J. Masselot,et al.  Lymphography in the initial evaluation of endometrial carcinoma , 1988, Gynecologic oncology.

[85]  B. Bundy,et al.  Surgical pathologic spread patterns of endometrial cancer: A gynecologic oncology group study , 1987, Cancer.

[86]  Guofu Zhang,et al.  The ability of ADC measurements in the assessment of patients with stage I endometrial carcinoma based on three risk categories , 2019, Acta radiologica.

[87]  A. Jemal,et al.  Cancer statistics, 2019 , 2019, CA: a cancer journal for clinicians.

[88]  Matthew P. Goetz,et al.  NCCN CLINICAL PRACTICE GUIDELINES IN ONCOLOGY , 2019 .

[89]  D. Radice,et al.  Evaluation of deep myometrial invasion in endometrial cancer patients: is dual-energy CT an option? , 2017, La radiologia medica.

[90]  M. Dueholm,et al.  Assessment of myometrial invasion in endometrial cancer using three-dimensional ultrasound and magnetic resonance imaging. , 2016, Acta obstetricia et gynecologica Scandinavica.

[91]  R. Rouzier,et al.  Contribution of Lymphoscintigraphy for Sentinel Lymph Node Biopsy in Women with Early Stage Endometrial Cancer: Results of the SENTI-ENDO Study , 2014, Annals of Surgical Oncology.

[92]  R. Kurman,et al.  WHO classification of tumours of female reproductive organs , 2014 .

[93]  H. Salvesen,et al.  Staging of endometrial carcinomas with MRI using traditional and novel MRI techniques. , 2012, Clinical radiology.

[94]  S. Galimberti,et al.  ADC maps in the prediction of pelvic lymph nodal metastatic regions in endometrial cancer , 2012, European Radiology.

[95]  V. Zanagnolo,et al.  Robotic surgery for endometrial cancer: comparison of perioperative outcomes and recurrence with laparoscopy, vaginal/laparoscopy and laparotomy. , 2011, European journal of gynaecological oncology.

[96]  P. Stentella,et al.  FIGO Stage I endometrial carcinoma: evaluation of lung metastases and follow-up. , 2008, European journal of gynaecological oncology.

[97]  R. Reznek,et al.  Recurrent endometrial cancer: patterns of recurrent disease and assessment of prognosis. , 2007, Clinical radiology.

[98]  ACOG practice bulletin, clinical management guidelines for obstetrician-gynecologists, number 65, August 2005: management of endometrial cancer. , 2005, Obstetrics and gynecology.

[99]  J. Higginson,et al.  International Agency for Research on Cancer. , 1968, WHO chronicle.

[100]  N. Dubrawsky.  Cancer statistics , 2022 .

[101]  D. Mutch,et al.  ACOG Practice Bulletin, clinical management guidelines for obstetrician-gynecologists number 98, October 2008 (replaces Practice Bulletin number 58, December 2004). Ultrasonography in pregnancy. , 2008, Obstetrics and gynecology.